Diego Abarzúa, Claudia Radojkovic, Santiago Quintana, Catalina Martínez, Natalia Barriga, Rodrigo Alonso, Enrique Guzman, Carlos Felipe Burgos, Andrea Sánchez
{"title":"LDLR外显子13-15重复的表型和分子特征:对家族性高胆固醇血症的影响","authors":"Diego Abarzúa, Claudia Radojkovic, Santiago Quintana, Catalina Martínez, Natalia Barriga, Rodrigo Alonso, Enrique Guzman, Carlos Felipe Burgos, Andrea Sánchez","doi":"10.1016/j.jacl.2025.06.023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature cardiovascular disease. Major rearrangements were among the first mutations identified in the low-density lipoprotein receptor (LDLR) gene and currently comprise approximately 10% of FH-causing variants. One of them is the exon13_15dup. However, the impact on the structure and function of the LDLR is poorly understood.</p><p><strong>Objective: </strong>To determine the structural and functional impact of the exon13_15dup variant in the LDLR gene in FH patients.</p><p><strong>Methods: </strong>The RNA extracted from CD14+ macrophage differentiation was obtained from non-consanguineous index cases carrying this mutation. Polymerase chain reaction and Sanger evaluated the junction sequence of the mutation sequenced. The obtained sequences were used to construct in silico models and perform molecular dynamics assays.</p><p><strong>Results: </strong>The exon13_15dup variant resulted in substantial structural alterations within the LDLR, producing a truncated protein lacking both the transmembrane and cytoplasmic domains.</p><p><strong>Conclusions: </strong>The structural changes caused by the exon13_15dup variant significantly impair the functionality of the LDLR protein, contributing to the clinical phenotype observed in patients with FH.</p>","PeriodicalId":15392,"journal":{"name":"Journal of clinical lipidology","volume":" ","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Phenotypic and molecular characterization of the exon 13-15 duplication in LDLR: Implications for familial hypercholesterolemia.\",\"authors\":\"Diego Abarzúa, Claudia Radojkovic, Santiago Quintana, Catalina Martínez, Natalia Barriga, Rodrigo Alonso, Enrique Guzman, Carlos Felipe Burgos, Andrea Sánchez\",\"doi\":\"10.1016/j.jacl.2025.06.023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature cardiovascular disease. Major rearrangements were among the first mutations identified in the low-density lipoprotein receptor (LDLR) gene and currently comprise approximately 10% of FH-causing variants. One of them is the exon13_15dup. However, the impact on the structure and function of the LDLR is poorly understood.</p><p><strong>Objective: </strong>To determine the structural and functional impact of the exon13_15dup variant in the LDLR gene in FH patients.</p><p><strong>Methods: </strong>The RNA extracted from CD14+ macrophage differentiation was obtained from non-consanguineous index cases carrying this mutation. Polymerase chain reaction and Sanger evaluated the junction sequence of the mutation sequenced. The obtained sequences were used to construct in silico models and perform molecular dynamics assays.</p><p><strong>Results: </strong>The exon13_15dup variant resulted in substantial structural alterations within the LDLR, producing a truncated protein lacking both the transmembrane and cytoplasmic domains.</p><p><strong>Conclusions: </strong>The structural changes caused by the exon13_15dup variant significantly impair the functionality of the LDLR protein, contributing to the clinical phenotype observed in patients with FH.</p>\",\"PeriodicalId\":15392,\"journal\":{\"name\":\"Journal of clinical lipidology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of clinical lipidology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jacl.2025.06.023\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical lipidology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacl.2025.06.023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Phenotypic and molecular characterization of the exon 13-15 duplication in LDLR: Implications for familial hypercholesterolemia.
Background: Familial hypercholesterolemia (FH) is an inherited disorder characterized by elevated levels of low-density lipoprotein (LDL) cholesterol, significantly increasing the risk of premature cardiovascular disease. Major rearrangements were among the first mutations identified in the low-density lipoprotein receptor (LDLR) gene and currently comprise approximately 10% of FH-causing variants. One of them is the exon13_15dup. However, the impact on the structure and function of the LDLR is poorly understood.
Objective: To determine the structural and functional impact of the exon13_15dup variant in the LDLR gene in FH patients.
Methods: The RNA extracted from CD14+ macrophage differentiation was obtained from non-consanguineous index cases carrying this mutation. Polymerase chain reaction and Sanger evaluated the junction sequence of the mutation sequenced. The obtained sequences were used to construct in silico models and perform molecular dynamics assays.
Results: The exon13_15dup variant resulted in substantial structural alterations within the LDLR, producing a truncated protein lacking both the transmembrane and cytoplasmic domains.
Conclusions: The structural changes caused by the exon13_15dup variant significantly impair the functionality of the LDLR protein, contributing to the clinical phenotype observed in patients with FH.
期刊介绍:
Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner.
Sections of Journal of clinical lipidology will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.